Lactobacillus casei Zhang和Bifidobacterium lactis V9在益生菌酸乳中的应用

益生菌在酸乳中的应用已非常普遍,将Lactobacillus casei Zhang单独(样品A)以及与Bifidobacterium lactis V9复合(样品B),同酸乳发酵剂(G027)共同发酵益生菌酸乳,于4℃贮藏21 d。结果表明,整个贮藏期间2组样品间的黏度和持水性差异不显著;贮藏期间2组样品间L.casei Zhang的活菌数没有差异,且L.casei Zhang和B.lactis V9的活菌数不随贮藏时间而降低;L.casei Zhang和B.lactis V9复合益生菌酸奶感官评价优于单独添加L.casei Zhang酸乳。L.casei Zhang和B.lactis V9复合添加,更适合于益生菌酸乳的生产。     

益生菌Lactobacillus casei Zhang和Bifidobacterium lactis V9在活性乳酸菌饮料中的应用

以L.casei Zhang和B.lactis V9为发酵菌株制备活性乳酸菌饮料,评价2株益生菌对活性乳酸菌饮料感官品质的影响及在货架期内的存活稳定性,为L.casei Zhang和B.lactis V9在产品中的应用提供基础数据。研究结果显示,利用L.casei Zhang单独发酵制备活性乳酸菌饮料的最适添加量为1.0×107CFU/g,4℃28 d贮藏期内保持高于3.0×108CFU/g水平;最佳复配发酵组合为L.casei Zhang+B.animalis V9(1∶1,2.0×107CFU/g),4℃28 d贮藏期内样品中总的益生菌活菌数保持5.0×108CFU/g以上,且在口感和滋气味方面感官评价分值最高;B.animalis V9与L.casei Zhang共同发酵发生协同效应,B.animalis V9的添加可促进L.casei Zhang的增殖,且有利于改善L.casei Zhang单株发酵样品的感官品质。     

Lactobacillus delbrueckii subsp. bulgaricus和Streptococcus thermophilus接种比例对Bifidobacterium lactis益生菌发酵乳品质的影响

将Lactobacillus delbrueckii subsp.bulgaricus ND02(LB-ND02)和Streptococcus thermophilus ND03(ST-ND03)按1∶1、1∶10、1∶100、1∶1000接种于脱脂乳中,同时接入益生菌Bifidobacterium lactis V9(B.lactis V9,接种量为2.0×107g-1),于42℃进行发酵。通过对发酵及贮藏过程中发酵乳指标的测定,评价LB-ND02和ST-ND03的接种比例对发酵乳品质的影响。结果表明,随着LB-ND02接种比例减小,凝乳时间显著延长,B.lactis V9活菌数显著提高。4℃贮藏28 d后,随LB-ND02接种比例减小,B.lactis V9存活率差异显著,后酸化也显著减弱。研究发现,LB-ND02和ST-ND03的接种比例,显著影响发酵乳的发酵时间、B.lactis V9活菌数、后酸化及黏度。     

益生菌L.casei Zhang和B.lactis V9在发酵乳中发酵特性的评价

以L.casei Zhang和B.lactis V9为研究对象,评价其发酵特性及对发酵乳品质的影响。研究结果显示,4℃下贮藏21 d,L.casei Zhang和B.lactis V9的添加对发酵乳的p H值、滴定酸度(TA)、黏度和持水性基本无影响;L.casei Zhang和B.lactis V9在发酵乳中存活稳定;B.lactis V9的添加可促进L.casei Zhang的增殖,同时可进一步改善L.casei Zhang发酵乳的气味和风味。     

Bifidobacterium lactis V9在脱脂乳粉中贮藏稳定性的研究

研究Bifidobacterium lactis V9(B.lactis V9)与双歧杆菌B在脱脂乳粉中不同温度条件下存活稳定性,并以Arrhenius方程反映温度与菌体损失率之间关系,预测B.lactis V9与双歧杆菌B相关乳粉产品货架期内菌体损失情况。结果表明,B.lactis V9与双歧杆菌B随温度升高,菌体损失率增大。两菌株在37℃贮藏28 d后,活菌数下降最明显,约两个数量级,且在不同贮藏温度下活菌数随时间变化情况无显著性差异。通过Arrhenius方程和菌体递减模型,建立了B.lactis V9和双歧杆菌B在不同温度下货架期预测模型,该模型可以较好的预测含B.lactis V9和双歧杆菌B乳粉产品在某一温度下菌体损失率和货架期寿命。     

荧光定量PCR法检测益生菌饮料中Lactobacillus casei Zhang和Bifidobacterium lactis V9

益生菌活菌数是益生菌产品最重要的指标,而检测益生菌方法的准确性和科学性则至关重要.本文采用荧光定量PCR法同时定量检测益生菌饮料中Lactobacillus casei Zhang(L.casei Zhang)和Bifidobacterium lactis V9(B.lactis V9)的活菌数,并与平板菌落计数法进行比较.结果表明,荧光定量PCR法测得L.casei Zhang活菌数与平板菌落计数法测得活菌数差异不显著;而采用荧光定量PCR法测得B.lactis V9活菌数显著高于平板菌落计数法.荧光定量PCR法灵敏、特异、简便快速,可定量检测并真实反应L.casei Zhang和B.lactis V9的活菌数.     

益生菌Lactobacillus casei Zhang对酸奶风味、质地及感官特性的影响

将益生菌Lactobacillus casei Zhang(Lb. casei Zhang)以1.0×107g-1的添加量与商业酸奶发酵荆YC-X11共同接种进行发酵乳制备.发酵结束(pH=4.5)于4℃冷藏24 h后,分别测定发酵乳样品的酸度、黏度、脱水收缩性、挥发性风味物质、L.delbrueckii subsp.Bulgaricus、S.thermophilus和Lb.casei Zhang活菌数及对其进行感官鉴评.结果表明.Lb.casei Zhang对发酵乳样品的酸度、黏度、脱水收缩性、S.ther-mophilus活菌数无影响(P>0.05),可促进L.delbrueckii subsp.Bulgaricus生长(P<0.05),并使酸奶样品中挥发性风味物质总的质量分数提高17.1%.从而总体上提高发酵乳的感官品质.同时Lb.casei Zhang在发酵乳中具有良好的稳定性.因而益生菌Lb.casei Zhang与商业酸奶发酵剂YC-X11复配进行发酵乳生产具有极大的可行性.     

益生菌干酪乳杆菌Zhang和乳双歧杆菌V9发酵乳胞外多糖含量对流变学特性、质构和稳定性的影响

干酪乳杆菌Zhang和乳双歧杆菌V9是我国自主开发具有良好益生特性的益生菌,发酵乳是益生菌的最优载体之一.本研究以2株益生菌应用于发酵乳为研究对象,采用多频扩散波谱法研究发酵过程中的流变学特性,通过稠度、硬度、内聚性和黏度指数测定分析发酵乳的质构特性,并分析贮藏期间活菌数和稳定性,胞外多糖(EPS)含量.结果表明,干酪...     

球杆菌比例、固形物含量和灌装方式对酸奶保存期的影响

选用球杆菌比例、非脂乳固形物含量和灌装方式对酸奶的保存期进行了研究。结果表明:球杆菌比例为1.5∶1(S.t∶L.b=1.5∶1)、非脂乳固形物含量为12.3%,采用无菌灌装方式生产的酸奶,在冷藏条件下可保存24d,此时乳酸菌活菌数在6.0×108mL-1以上,比普通酸奶延长保存期15d。若采用球杆菌比例为2∶1、非脂乳固形物含量为15.3%,无菌灌装的酸奶可冷藏32d。     

配方和工艺条件对冷冻酸奶冰淇淋益生菌活菌数的影响

实验分析了综合产品配方和工艺条件对冷冻酸奶冰淇淋产品活菌数以及感官的影响情况,实验从发酵剂的筛选、配方中固形物的添加、凝冻工艺等几方面分别进行讨论,通过测定产品中的活菌数,同时对产品感官进行综合评分,最终确定当嗜热链球菌、保加利亚乳杆菌、嗜酸乳杆菌、副干酪乳杆菌以250∶25∶55∶33的添加比例作为复配发酵剂进行发酵...     

Viability of probiotic micro-organisms (Lactobacillus casei Shirota and Bifidobacterium animalis subspp. lactis) in a milk-based dessert with cranberry sauce

The objective of this study was to evaluate the survival of two probiotic micro-organisms, Lactobacillus casei Shirota and Bifidobacterium animalis subspp . lactis , in a milk-based dessert (2.7% fat) with cranberry sauce added. B. lactis had a final concentration of 1.99 × 10⁶ cfu/g after 21 days of study, with a logarithmic decrease of 8.87%. On other hand, L. casei Shirota had a final concentration of 2.05 × 10⁷ cfu/g at the end of the same period, a logarithmic decrease of 8.41%. Statistical analysis showed that significant differences existed between both micro-organisms and over various storage times, the more viable micro-organism being L. casei Shirota , which decreased less than one logarithmic cycle after 21 days.     

Effect of milk base and starter culture on acidification,texture, and probiotic cell counts in fermented milk processing

In the present work, the compared effect of milk base and starter culture on acidification, texture, growth, and stability of probiotic bacteria in fermented milk processing, was studied. Two strains of probiotic bacteria were used, Lactobacillus acidophilus LA5 and L. rhamnosus LR35, with two starter cultures. One starter culture consisted only of Streptococcus thermophilus ST7 (single starter culture); the other was a yogurt mixed culture with S. thermophilus ST7 and L. bulgaricus LB12 (mixed starter culture). For the milk base preparation, four commercial dairy ingredients were tested (two milk protein concentrates and two casein hydrolysates). The resulting fermented milks were compared to those obtained with control milk (without enrichment) and milk added with skim milk powder. The performance of the two probiotic strains were opposite. L. acidophilus LA5 grew well on milk but showed a poor stability during storage. L. rhamnosus LR35 grew weakly on milk but was remarkably stable during storage. With the strains tested in this study, the use of the single starter culture and the addition of casein hydrolysate gave the best probiotic cell counts. The fermentation time was of about 11 h, and the probiotic level after five weeks of storage was greater than 106 cfu/ml for L. acidophilus LA5 and 10(7) cfu/ml for L. rhamnosus LR35. However, an optimization of the level of casein hydrolysate added to milk base has to be done, in order to improve texture and flavor when using this dairy ingredient.     

Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus

The purpose of this study was to investigate the effects of probiotic and conventional yogurt on the lipid profile in type 2 diabetic people. In a randomized double-blind controlled trial, 60 people (23 males and 37 females) with type 2 diabetes and low-density lipoprotein cholesterol (LDL-C) greater than 2.6 mmol/L were assigned to 2 groups. Participants consumed daily 300 g of probiotic yogurt containing Lactobacillus acidophilus La5 and Bifidobacterium lactis Bb12 or 300 g of conventional yogurt for 6 wk. Fasting blood samples, anthropometric measurements and 3-d, 24-h dietary recalls were collected at the baseline and at the end of the trial. Probiotic yogurt consumption caused a 4.54% decrease in total cholesterol and a 7.45% decrease in LDL-C compared with the control group. No significant changes from baseline were shown in triglyceride and high-density lipoprotein cholesterol (HDL-C) in the probiotic group. The total cholesterol:HDL-C ratio and LDL-C:HDL-C ratio as atherogenic indices significantly decreased in the probiotic group compared with the control group. Probiotic yogurt improved total cholesterol and LDL-C concentrations in type 2 diabetic people and may contribute to the improvement of cardiovascular disease risk factors.     

Effect of high-pressure homogenization, nonfat milk solids, and milkfat on the technological performance of a functional strain for the production of probiotic fermented milks

The aim of this research was the evaluation of the effects of milkfat content, nonfat milk solids content, and high-pressure homogenization on 1) fermentation rates of the probiotic strain Lactobacillus paracasei BFE 5264 inoculated in milk; 2) viability loss of this strain during refrigerated storage; and 3) texture parameters, volatile compounds, and sensorial properties of the coagula obtained. The data achieved suggested a very strong effect of the independent variables on the measured attributes of fermented milks. In fact, the coagulation times were significantly affected by pressure and added milkfat, and the rheological parameters of the fermented milk increased with the pressure applied to the milk for added nonfat milk solids concentrations lower than 3%. Moreover, the polynomial models and the relative response surfaces obtained permitted us to identify the levels of the 3 independent variables that minimized the viability loss of the probiotic strain used during refrigerated storage.     

Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults

This randomized, placebo-controlled, double blind, parallel dose-response study investigated the impact of 4-week commercial yoghurt consumption supplemented with Bifidobacterium animalis subsp. lactis (BB-12) and Lactobacillus acidophilus (LA-5) on fecal bacterial counts of healthy adults. Fifty-eight volunteers were randomly assigned to three different groups: 1. placebo (no probiotic, no starter and no green tea extract); 2. Yoptimal (10⁹ cfu/100 g of BB-12 and LA-5 and 40 mg of green tea extract) and 3. Yoptimal-10 (10¹⁰ cfu/100 g of BB-12, 10⁹ cfu/100 g of LA-5 and 40 mg of green tea extract). These yoghurt products also contained Lactobacillus delbrueckii subsp. bulgaricus (10⁷ cfu/100 g) and Streptococcus thermophilus (10¹⁰ cfu/100 g). The quantitative PCR (qPCR) results showed that there were significant increases (P = 0.02) in bifidobacteria counts with the Yoptimal treatment as compared to baseline. The fecal numbers of B. animalis subsp. lactis and LA-5 significantly increased in the two probiotic treatments compared to the placebo treatment. Viable counts of fecal lactobacilli were significantly higher (P = 0.05) and those of enterococci were significantly lower (P = 0.04) after the intervention when compared to placebo. No significant difference was observed between treatments in volunteers' weight, waist girth, blood pressure, fasting plasma triglyceride and HDL-C concentrations, as well as cholesterol/HDL-cholesterol ratio. However, a significant increase in plasma cholesterol levels was observed in the placebo group (P = 0.0018) but the levels remained stable in the two probiotic yoghurt groups. These results show that probiotic strains supplemented in the form of yoghurt remain active during gut transit and are associated with an increase in beneficial bacteria and a reduction in potentially pathogenic bacteria. This trial was registered at clinicaltrials.gov as NCT00730626.     

Comparison of the effects of single probiotic strains Lactobacillus casei Zhang and Bifidobacterium animalis ssp. lactis Probio-M8 and their combination on volatile and nonvolatile metabolomic profiles of yogurt

There has been a growing interest in cofermentation of starter cultures with probiotics in milk. In this study, we analyzed the effects of adding the single probiotics Lactobacillus casei Zhang (Zhang) or Bifidobacterium animalis ssp. lactis Probio-M8 (M8) or a combination of Zhang and M8 to starter cultures on volatile and nonvolatile metabolomic profiles after 14 d of storage at 4°C and compared using a liquid chromatography-tandem mass spectrometry (LC-MS) and GC-MS-based metabolomics approach. Principal component analysis, heatmap plots, and Spearman correlation results showed that Zhang alone had a greater effect on volatile and nonvolatile metabolomic profiles than M8 alone. The combination of Zhang and M8 had additive effects on the production of metabolites. For volatile metabolites, the levels of acetaldehyde, diacetyl, acetoin, and acetic acid were higher for the combination of Zhang and M8 compared with either single probiotic culture. Significantly increased nonvolatile components induced by adding Zhang were identified were enriched in the galactose, amino- and nucleotide sugar, fructose and mannose, purine, phenylalanine metabolism, and arginine biosynthesis pathways. The metabolism and biosynthesis of starch, sucrose, tyrosine, galactose metabolism, and aminoacyl-tRNA biosynthesis were significantly upregulated by adding the combination of Zhang and M8. This work provides a detailed insight into different effects of Zhang and M8 used alone or in combination on the volatile and nonvolatile metabolomic profiles of yogurts.     

Effect of buckwheat flour and oat bran on growth and cell viability of the probiotic strains Lactobacillus rhamnosus IMC 501®, Lactobacillus paracasei IMC 502® and their combination SYNBIO®, in synbiotic fermented milk

Fermented foods have a great significance since they provide and preserve large quantities of nutritious foods in a wide diversity of flavors, aromas and texture, which enrich the human diet. Originally fermented milks were developed as a means of preserving nutrients and are the most representatives of the category. The first aim of this study was to screen the effect of buckwheat flour and oat bran as prebiotics on the production of probiotic fiber-enriched fermented milks, by investigating the kinetics of acidification of buckwheat flour- and oat bran-supplemented milk fermented by Lactobacillus rhamnosus IMC 501®, Lactobacillus paracasei IMC 502® and their 1:1 combination named SYNBIO®. The probiotic strains viability, pH and sensory characteristics of the fermented fiber-enriched milk products, stored at 4 °C for 28 days were also monitored. The results showed that supplementation of whole milk with the tested probiotic strains and the two vegetable substrates results in a significant faster lowering of the pH. Also, the stability of L. rhamnosus IMC 501®, L. paracasei IMC 502® and SYNBIO® during storage at 4 °C for 28 days in buckwheat flour- and oat bran-supplemented samples was remarkably enhanced. The second aim of the study was to develop a new synbiotic product using the best combination of probiotics and prebiotics by promoting better growth and survival and be acceptable to the consumers with high concentration of probiotic strain. This new product was used to conduct a human feeding trial to validate the fermented milk as a carrier for transporting bacterial cells into the human gastrointestinal tract. The probiotic strains were recovered from fecal samples in 40 out of 40 volunteers fed for 4 weeks one portion per day of synbiotic fermented milk carrying about 10⁹ viable cells.